Calidi Biotherapeutics Inc
CLDI0.599USD
+0.009+1.44%
交易中 （美东）报价延迟15分钟
19.04M总市值
亏损市盈率 TTM
关于 Calidi Biotherapeutics Inc 公司
Calidi Biotherapeutics, Inc. 是一家临床阶段的免疫肿瘤学公司，其技术旨在武装免疫系统对抗癌症。该公司的新型干细胞平台利用强大的同种异体干细胞，能够携带溶瘤病毒有效载荷，用于多种肿瘤适应症，包括高级别胶质瘤和实体瘤。其临床阶段的现成通用细胞递送平台旨在保护、扩增和增强溶瘤病毒。其临床前现成的包膜病毒疗法旨在针对播散性实体瘤。这种双重方法将有可能治疗甚至预防转移性疾病。其候选产品包括用于复发性 HGG 的 CLD-101、用于晚期实体瘤的 CLD-201 和用于某些肺癌和转移性实体瘤的 CLD-400 (RTNova)。除其在研产品候选药物外，该公司还致力于 CLD-301 (AAA) 的多种适应症的发现研究。
公司简介
公司代码CLDI
公司名称Calidi Biotherapeutics Inc
上市日期Sep 10, 2021
CEODr. Eric Poma, Ph.D.
员工数量28
证券类型Ordinary Share
年结日Sep 10
公司地址4475 Executive Drive, Suite 200
城市SAN DIEGO
上市交易所NYSE American Consolidated
国家United States of America
邮编92121
电话18587949600
网址https://www.calidibio.com/
公司代码CLDI
上市日期Sep 10, 2021
CEODr. Eric Poma, Ph.D.
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Scott Leftwich
Mr. Scott Leftwich
Independent Director
Independent Director
259.54K
--
Mr. James A. Schoeneck
Mr. James A. Schoeneck
Independent Chairman of the Board
Independent Chairman of the Board
114.13K
--
Mr. Alan R. Stewart
Mr. Alan R. Stewart
Independent Director
Independent Director
28.98K
--
Ms. Wendy Pizarro Campbell, Esq.
Ms. Wendy Pizarro Campbell, Esq.
Chief Administrative Officer, Chief Legal Officer, Chief Diversity Officer, Corporate Secretary
Chief Administrative Officer, Chief Legal Officer, Chief Diversity Officer, Corporate Secretary
--
--
Mr. Allan J. Camaisa
Mr. Allan J. Camaisa
Independent Director
Independent Director
--
--
Col. (Retd.) George E. Peoples, Jr., M.D.
Col. (Retd.) George E. Peoples, Jr., M.D.
Independent Director
Independent Director
--
--
Mr. Stephen Jasper
Mr. Stephen Jasper
Investor Relations
Investor Relations
--
--
Dr. Eric Poma, Ph.D.
Dr. Eric Poma, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Travis Clifton, M.D.
Dr. Travis Clifton, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Andrew C. Jackson
Mr. Andrew C. Jackson
Chief Financial Officer
Chief Financial Officer
--
-100.00%
名称
名称/职务
职务
持股
持股变动
Mr. Scott Leftwich
Mr. Scott Leftwich
Independent Director
Independent Director
259.54K
--
Mr. James A. Schoeneck
Mr. James A. Schoeneck
Independent Chairman of the Board
Independent Chairman of the Board
114.13K
--
Mr. Alan R. Stewart
Mr. Alan R. Stewart
Independent Director
Independent Director
28.98K
--
Ms. Wendy Pizarro Campbell, Esq.
Ms. Wendy Pizarro Campbell, Esq.
Chief Administrative Officer, Chief Legal Officer, Chief Diversity Officer, Corporate Secretary
Chief Administrative Officer, Chief Legal Officer, Chief Diversity Officer, Corporate Secretary
--
--
Mr. Allan J. Camaisa
Mr. Allan J. Camaisa
Independent Director
Independent Director
--
--
Col. (Retd.) George E. Peoples, Jr., M.D.
Col. (Retd.) George E. Peoples, Jr., M.D.
Independent Director
Independent Director
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 7月2日 周三
更新时间: 7月2日 周三
持股股东
股东类型
持股股东
持股股东
占比
Armistice Capital LLC
9.62%
Jamir Trust
1.76%
BMO Nesbitt Burns Inc.
1.42%
Kessler (Judd S)
1.08%
The Vanguard Group, Inc.
1.02%
Other
85.09%
持股股东
持股股东
占比
Armistice Capital LLC
9.62%
Jamir Trust
1.76%
BMO Nesbitt Burns Inc.
1.42%
Kessler (Judd S)
1.08%
The Vanguard Group, Inc.
1.02%
Other
85.09%
股东类型
持股股东
占比
Hedge Fund
9.77%
Investment Advisor
4.03%
Individual Investor
2.85%
Corporation
2.58%
Investment Advisor/Hedge Fund
1.87%
Research Firm
0.16%
Venture Capital
0.05%
Other
78.69%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
100
7.64M
29.37%
+4.42M
2025Q1
104
7.65M
23.70%
+4.58M
2024Q4
102
3.31M
11.93%
+1.13M
2024Q3
94
2.46M
23.73%
+462.38K
2024Q2
111
2.30M
38.69%
-356.37K
2024Q1
113
2.02M
47.34%
-720.95K
2023Q4
108
2.00M
46.75%
-874.01K
2023Q3
95
1.86M
60.12%
+4.51K
2023Q2
68
377.00K
91.33%
-1.38M
2023Q1
66
400.63K
97.05%
-1.31M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Armistice Capital LLC
3.32M
10.45%
+3.32M
--
Mar 31, 2025
Jamir Trust
608.38K
1.91%
--
--
Jun 20, 2025
BMO Nesbitt Burns Inc.
489.80K
1.54%
+477.30K
+3818.40%
Mar 31, 2025
Kessler (Judd S)
372.98K
1.17%
+372.98K
--
May 01, 2024
The Vanguard Group, Inc.
353.38K
1.11%
+292.01K
+475.78%
Mar 31, 2025
AJC Capital LLC
281.51K
0.89%
--
--
Jun 20, 2025
Leftwich (Scott)
259.54K
0.82%
--
--
Jun 20, 2025
Geode Capital Management, L.L.C.
251.92K
0.79%
+91.90K
+57.43%
Mar 31, 2025
Belpointe Asset Management LLC
249.83K
0.79%
+249.83K
--
Mar 31, 2025
Hightower Advisors, LLC
119.47K
0.38%
+17.20K
+16.81%
Mar 31, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Jul 05, 2024
Merger
10<1
Jul 05, 2024
Merger
10<1
Jul 05, 2024
Merger
10<1
Jul 05, 2024
Merger
10<1
公告日期
类型
比率
Jul 05, 2024
Merger
10<1
Jul 05, 2024
Merger
10<1
Jul 05, 2024
Merger
10<1
Jul 05, 2024
Merger
10<1
